{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T21:08:40Z","timestamp":1784754520033,"version":"3.55.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Morvan syndrome (MoS) is an uncommon male-dominant autoimmune disorder marked by peripherally innervated hyperexcitability, autonomic disturbances, and encephalopathic encephalopathy, frequently with mass complaints manifesting as neuromyotonia (involuntary jerking, twitching, and stiffening of muscles), myotonia, neuropathic pain, hyperhidrosis, severe constipation, and severe sleep disturbances accompanied by dream reenactments, agrypnia agitation, and delusions, associated with autoantibodies to voltage-gated and potassium channel complexes such as anti-contactin\u2013associated protein-like 2 (Caspr2) antibody. All this misery can be very disabling and even life-threatening. Reported cases show an unforeseeable outcome, with fatalities occurring even in those who initially responded. It has been reported that patients have reacted to immunologic therapies\u2014corticosteroids, intravenous immunoglobulins, plasma exchanges, azathioprine, cyclophosphamide, rituximab, or carbamazepine, gabapentin, and clonazepam. However, no long-term effective cure has yet been found for this condition. Clinicians and researchers increasingly emphasize alternative and complementary medicine, with a growing trend toward traditional Chinese medicine (TCM).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>Following glucocorticoid therapy, all 3 patients experienced a recurrence of the disease. Patients 1 and 2 observed symptomatic relief after intravenous immunoglobulin administration; however, upon discontinuation of the treatment, their conditions relapsed and worsened compared with the previous state.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The 3 patients were definitively diagnosed with serum Caspr2-positive MoS, accompanied by a constellation of neurological manifestations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The 3 patients were treated under the guidance of TCM theory. According to the principles of TCM, the patients were characterized by the deficiency of <jats:italic toggle=\"yes\">Yin<\/jats:italic>, so the prescriptions were as follows: Shaoyao-Gancao decoction combined with Sanjia-Fumai decoction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After the application of TCM, there was a reversal of neuropsychiatric manifestations such as unintentional rippling, jerking, muscle stiffness, myokymia, hyperhidrosis, and extreme constipation. Patients\u2019 quality of life improved significantly; to date, they have achieved Karnofsky Performance Status scores of 100, and the anti-Caspr2 antibody result in case 2 dropped from 1:32 to normal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We first report the effective treatment of the MoS case series with TCM as complementary and alternative medicine.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040159","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T18:05:02Z","timestamp":1730138702000},"page":"e40159","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A case series: Three cases of Morvan\u2019s syndrome as a rare autoimmune disorder with anti-Caspr2 antibody"],"prefix":"10.1097","volume":"103","author":[{"given":"Dan","family":"Ma","sequence":"first","affiliation":[{"name":"Clinical Department of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Renmin Hospital of Wuhan University, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengbo","family":"Mo","sequence":"additional","affiliation":[{"name":"Clinical Department of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilian","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Renmin Hospital of Wuhan University, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Renmin Hospital of Wuhan University, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Renmin Hospital of Wuhan University, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7027-7166","authenticated-orcid":false,"given":"Enfeng","family":"Song","sequence":"additional","affiliation":[{"name":"Clinical Department of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China"},{"name":"Department of Traditional Chinese Medicine, Renmin Hospital of Wuhan University, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1097\/JTO.0000000000000300","article-title":"Paraneoplastic disorders in thymoma patients.","volume":"9","author":"Evoli","year":"2014","journal-title":"J Thorac Oncol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10072-009-0041-y","article-title":"Course and outcome of a voltage-gated potassium channel antibody negative Morvan\u2019s syndrome.","volume":"30","author":"Rinaldi","year":"2009","journal-title":"Neurol Sci"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12883-021-02205-9","article-title":"Morvan syndrome associated with LGI1 antibody: a case report.","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Neurol"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.lungcan.2021.01.012","article-title":"Caspr2 autoantibody-associated Morvan syndrome predating thymoma relapse by 30 months.","volume":"153","author":"Masrori","year":"2021","journal-title":"Lung Cancer"},{"issue":"Pt 12","key":"R5-20250503","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan\u2019s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels.","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/1941874415580597","article-title":"Morvan syndrome: a case report with patient narrative and video.","volume":"6","author":"Maskery","year":"2016","journal-title":"Neurohospitalist"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1212\/NXI.0000000000000371","article-title":"Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis.","volume":"4","author":"Joubert","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/jnnp.2009.174888","article-title":"Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome, and myasthenia gravis.","volume":"82","author":"Sadnicka","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R9-20250503","first-page":"97","article-title":"(2020). Mercury-induced autoimmunity: Report of two adolescent siblings with Morvan syndrome \u300aplus\u300b and review of the literature.","volume":"342","author":"P\u00e9rez","year":"5771","journal-title":"J Neuroimmunol"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(16)31459-3","article-title":"Morvan syndrome is a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies.","volume":"389","author":"Vale","year":"2017","journal-title":"Lancet"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s10072-018-3515-y","article-title":"Morvan\u2019s syndrome\u2014Is a pathogen behind the curtain?","volume":"39","author":"Singh","year":"2018","journal-title":"Neurol Sci"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/19390211.2013.830679","article-title":"The CARE guidelines: consensus-based clinical case report guideline development.","volume":"10","author":"Gagnier","year":"2013","journal-title":"J Dietary Suppl"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/CCO.0b013e3283306647","article-title":"Update on paraneoplastic neurological syndromes.","volume":"21","author":"Didelot","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0140-6736(17)30557-3","article-title":"Morvan just a syndrome\u2026!","volume":"389","author":"Somerville","year":"2017","journal-title":"Lancet (London, England)"},{"key":"R15-20250503","first-page":"003544","article-title":"A case of anti-Caspr2 autoimmune encephalitis associated with adenocarcinoma of the lung.","volume":"9","author":"Barbosa","year":"2022","journal-title":"Eur J Case Reports Internal Med"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12974-016-0533-7","article-title":"Morvan\u2019s syndrome and myasthenia gravis related to familial Mediterranean fever gene mutations.","volume":"13","author":"Koge","year":"2016","journal-title":"J Neuroinflammation"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/09273948.2022.2054823","article-title":"Bilateral panuveitis associated with Morvan syndrome: a case report and review of the literature.","volume":"31","author":"Kryshtalskyj","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"R18-20250503","first-page":"5812","article-title":"Treating insomnia of yin deficiency type with Sanjia Fumai decoction in febrile disease differentiation.","volume":"37","author":"Li-Kun","year":"2022","journal-title":"CJTCMP"},{"key":"R19-20250503","first-page":"209","article-title":"Study on the effect of Sanjia Fumai Decoction on syndrome score and curative effect of hyperhidrosis of children with hyperhidrosis due to Qi-Yin deficiency.","volume":"14","author":"Fan-Ying","year":"2020","journal-title":"Chin J Mod Drug Appl"},{"key":"R20-20250503","first-page":"2131","article-title":"Effect and mechanism of Sanjia Fumai Decoction on PIGD\u2014dominate Parkinson\u2019s disease with depression and sleep disorders.","volume":"44","author":"Fang","year":"2017","journal-title":"Liaoning J Tradit Chin Med"},{"key":"R21-20250503","first-page":"39","article-title":"Application and research of Shaoyao Gancao decoction in rehabilitation of musculoskeletal pain.","volume":"38","author":"Xiang-Rong","year":"2023","journal-title":"J Hebei TCM Pharmacol"},{"key":"R22-20250503","first-page":"721","article-title":"Research on key quality attributes of spasmolysis effect of the famous classical formula Shaoyao Gancao decoction.","volume":"40","author":"Yanli","year":"2023","journal-title":"Chin J Mod Appl Pharm"},{"key":"R23-20250503","first-page":"5","article-title":"Network pharmacological study on the mechanism of Shaoyao Gancao Decoction in the treatment of spastic paralysis after cerebral infarction.","volume":"19","author":"Tao","year":"2021","journal-title":"J China Prescription Drug"},{"key":"R24-20250503","first-page":"92","article-title":"Decoction with addition in the identification and treatment of primary hypertensive vertigo (Yin deficiency and wind movement syndrome).","volume":"11","author":"Yang","year":"2021","journal-title":"China Med Pharm"},{"key":"R25-20250503","first-page":"381","article-title":"Clinical observation of Sanjia Fumai Decoction in treating 80 cases of elderly patients with isolated systolic hypertension.","volume":"44","author":"Nan","year":"2022","journal-title":"Acta Acad Med Weifang"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases.","volume":"72","author":"Irani","year":"2012","journal-title":"Ann Neurol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/CPJ.0000000000000978","article-title":"CASPR2-related Morvan syndrome: autonomic, polysomnographic, and neuropsychological observations.","volume":"11","author":"Swayang","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/brain\/awac276","article-title":"Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis.","volume":"146","author":"G\u00f6vert","year":"2023","journal-title":"Brain"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1212\/WNL.54.3.771","article-title":"Morvan\u2019s syndrome associated with voltage-gated K+ channel antibodies.","volume":"54","author":"Barber","year":"2000","journal-title":"Neurology"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome, and acquired neuromyotonia.","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","article-title":"The value of LGI1, Caspr2, and voltage-gated potassium channel antibodies in encephalitis.","volume":"13","author":"van Sonderen","year":"2017","journal-title":"Nat Rev Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:19:36Z","timestamp":1746317976000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":31,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040159","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}